卵巢癌的体外诊断多变量指数测定(IVDMIA):收获多种生物标志物的力量。

Reviews in obstetrics & gynecology Pub Date : 2012-01-01

Zhen Zhang

{"title":"卵巢癌的体外诊断多变量指数测定(IVDMIA):收获多种生物标志物的力量。","authors":"Zhen Zhang","doi":"","DOIUrl":null,"url":null,"abstract":"In this review, OVA1® (Vermillion, Inc., Austin, TX), the first in vitro diagnostic multivariate index assay (IVDMIA) of protein biomarkers cleared by the US Food and Drug Administration (FDA), is used to explain the concept behind IVDMIA, the use of multiple markers to improve clinical performance of a diagnostic tool, and the key considerations in the development of IVDMIA.","PeriodicalId":21170,"journal":{"name":"Reviews in obstetrics & gynecology","volume":"5 1","pages":"35-41"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349922/pdf/RIOG005001_0035.pdf","citationCount":"0","resultStr":"{\"title\":\"An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers.\",\"authors\":\"Zhen Zhang\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this review, OVA1® (Vermillion, Inc., Austin, TX), the first in vitro diagnostic multivariate index assay (IVDMIA) of protein biomarkers cleared by the US Food and Drug Administration (FDA), is used to explain the concept behind IVDMIA, the use of multiple markers to improve clinical performance of a diagnostic tool, and the key considerations in the development of IVDMIA.\",\"PeriodicalId\":21170,\"journal\":{\"name\":\"Reviews in obstetrics & gynecology\",\"volume\":\"5 1\",\"pages\":\"35-41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349922/pdf/RIOG005001_0035.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in obstetrics & gynecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in obstetrics & gynecology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在这篇综述中，OVA1®(Vermillion, Inc.， Austin, TX)是第一个被美国食品和药物管理局(FDA)批准的蛋白质生物标志物的体外诊断多变量指数测定法(IVDMIA)，用于解释IVDMIA背后的概念，使用多种标志物来提高诊断工具的临床表现，以及发展IVDMIA的关键考虑因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers.

In this review, OVA1® (Vermillion, Inc., Austin, TX), the first in vitro diagnostic multivariate index assay (IVDMIA) of protein biomarkers cleared by the US Food and Drug Administration (FDA), is used to explain the concept behind IVDMIA, the use of multiple markers to improve clinical performance of a diagnostic tool, and the key considerations in the development of IVDMIA.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Reviews in obstetrics & gynecology

自引率

0.00%

发文量